<DOC>
	<DOCNO>NCT00715988</DOCNO>
	<brief_summary>The Primary objective proposal determine population kinetics methadone enantiomer preterm newborns infant 29 week 48 week post menstrual age ( PMA ) 1 week old old establish correlation kinetics PMA determine bioavailability enterally administer methadone newborn young infant . The secondary objective proposal explore possible genotypic change CYP3A4-3A7-3A5 , CYP2B6 , CYP2C8 , CYP2C19 , CYP2D6 PGO kinetics methadone neonates young infant test safety methadone population correlate plasma concentration methadone enantiomer , S-methadone R-methadone , change cardiac repolarization measurement correct QT , heart rate , blood pressure .</brief_summary>
	<brief_title>Methadone Pharmacokinetics Cardiac Effects Newborns</brief_title>
	<detailed_description>Painful procedure frequent NICU care sick newborn . Newborns capable perceive pain time fetal development reach current limit viability around 23-24 week post menstrual age.1 Painful procedure include suction mechanical ventilation , thoracostomy tube placement , heel lance venipuncture blood sampling , care follow surgical procedure PDA ligation bowel resection . Simons et al recently report number painful procedure large NICU Rotterdam provide review frequency procedures NICU's.2 This review show discharge NICU , newborn may experience many 376 painful procedure many 61 painful procedure single day ( procedure observe report ) . The frequent procedure heel lance suctioning , associate need mechanical ventilation . Topical treatment pain heel lance successful EMLA3 tetracaine.4 During initial NICU care infant support mechanical ventilation , systemic analgesia usually provide parenteral treatment fentanyl morphine . Most neonate extubated soon birth , continue systemic treatment analgesic need . Other neonate problem associate chronic pain continue painful procedure , surgical problem , chronic lung disease , airway anomaly , pulmonary hypoplasia pulmonary hypertension follow ECMO congenital diaphragmatic hernia repair . These patient often require mechanical ventilation week sometimes month . During prolonged care , systemic analgesia change enteral dosing reduce risk infection associate central catheter reduce number intravenous catheter insertion . Morphine fentanyl administer enterally provide reliable systemic concentration effect due first-pass metabolism . Fentanyl undergoes first-pass metabolism CYP3A4 passage intestine liver . Morphine undergoes first pas hepatic metabolism primarily UGT2B7 . In addition morphine , one major metabolite , 3-glucuronide , anti-analgesic cause dysphoria . An effective well-characterized systemic analgesic administer enterally need care infant require prolonged analgesic treatment methadone meet need . Methadone treatment adult provide effective systemic analgesia enteral administration bind mu opioid receptor wide range report half-lives 5 130 hrs,5 2 50 hrs,6 33 46 hr ; 7 bioavailability range 41 95 % .8 , 9 Recently , methadone report prolong QTc adult receive large dos methadone chronic treatment , often additional predispose factor QT prolongation . Methadone dispense racemic mixture whose enantiomer different potency analgesia bind myocardium potentially prolong QT . In addition different enantiomer exhibit complex kinetics adult undergo metabolism , primarily CYP3A4 , CYP2B6 , CYP2C19 . This study evaluate kinetics bioavailability methadone enantiomer effect QT neonates young infant .</detailed_description>
	<mesh_term>Methadone</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Patients must NICU PICU continuous cardiorespiratory monitoring 2 . PMA 29 0/7 48 6/7 week ( EGA birth ( wks ) + postnatal age wks ) start study 3 . Weight &gt; 1499 gm time enrollment 4 . Postnatal age 3 day 5 . Arterial venous catheter suitable blood sample separate i.v . infusion site prefer , essential 6 . Currently treat methadone bolus dose fentanyl morphine bolus dose infusion clinical indication expect treat least 12 day opioids study single dose pharmacokinetics treat 35 day study bioavailability 7 . Hematocrit â‰¥35 % 8 . Parental permission 9 . Approval patient 's attend physician Treatment Scheme 1 , study 48 hr single i.v . dose methadone 10 . Feeding feed 11 . Mechanically ventilated Treatment Scheme 2 study 24 48 hr single i.v . dose methadone AND single enteral dose methadone end sample first dose ; order dos randomize . If caregiver feel patient sedate end pK sample Dose , 1 , Dose 2 delay patient judge need analgesic treatment . 12 . Tolerating enteral feed 3 consecutive day study EXCLUSION CRITERIA 1 . Clinically diagnose liver dysfunction 2 . Clinically diagnosed kidney dysfunction urine output &lt; 1.0 ml/kg/hr 3 . Gastrointestinal malformation dysfunction might interfere enteral drug absorption 4 . Congenital anomaly condition think incompatible life 5 . History arrhythmia , exclude bradycardia associate apnea 6 . Unstable cardiorespiratory status 7 . Serum K+ &lt; 3.0 mEq/L 8 . QTc [ H ] &gt; 0.449 m use Hodges correction =QT + 1.75 ( rate 60 ) . 9 . Family history unexplained early cardiac death , syncope , long QT syndrome primary relative : sibling , parent , grandparent , aunts/uncles . 10 . Treatment inhibitor inducer CYP3A4 , CYP2B6 , CYP2D6 PGP include : amiodarone , carbamazepine , ciprofloxacin , clarithromycin , clotrimazole , dexamethasone , erythromycin , ethosuximide , fluconazole , fluoxetine , fluvoxamine , grapefruit juice , indinavir , itraconazole , ketoconazole , metronidazole , miconazole , nelfinavir , paroxetine , phenobarbital , phenytoin , quercetin , quinidine , rifabutin , rifampin , ritonavir , saquinavir , sulfadimidine , sulfinpyrazone , troleandomycin</criteria>
	<gender>All</gender>
	<minimum_age>29 Weeks</minimum_age>
	<maximum_age>48 Weeks</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Methadone</keyword>
	<keyword>analgesia</keyword>
	<keyword>newborn</keyword>
	<keyword>QT prolongation</keyword>
	<keyword>Young Infants</keyword>
</DOC>